Editorial: Epigenetic biomarkers for cancer risk stratification and patient management

• Miljana Tanić,
• Miljana Tanić,
• Simone Ecker,
• Iben Lyskjær,
• Iben Lyskjær

Affiliations

Miljana Tanić

Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia

Miljana Tanić

Department of Cancer Biology, UCL Cancer Institute, University College London, London, United Kingdom

Simone Ecker

Department of Cancer Biology, UCL Cancer Institute, University College London, London, United Kingdom

Iben Lyskjær

Department of Cancer Biology, UCL Cancer Institute, University College London, London, United Kingdom

Iben Lyskjær

Department of Molecular Medicine, Aarhus University Hospital, Aarhus University, Aarhus, Denmark